Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy

OBJECTIVE: Assess the longer‐term efficacy and safety of adjunctive perampanel (up to 12 mg/day) in patients aged ≥12 years with generalized tonic–clonic (GTC) seizures from the Open‐label Extension (OLEx) Phase of Study 332 to determine whether responses obtained during the Core Study are maintaine...

Descripción completa

Detalles Bibliográficos
Autores principales: French, Jacqueline A., Wechsler, Robert T., Trinka, Eugen, Brandt, Christian, O'Brien, Terence J., Patten, Anna, Salah, Alejandro, Malhotra, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436298/
https://www.ncbi.nlm.nih.gov/pubmed/35445567
http://dx.doi.org/10.1002/epi4.12602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436298/
https://www.ncbi.nlm.nih.gov/pubmed/35445567
http://dx.doi.org/10.1002/epi4.12602

Ejemplares similares